|
Annual Scientific Meeting
San Francisco Neurological Society Annual Meeting
- March 12-14, 2004, The Lodge at Sonoma, A Renaissance Resort & Spa -
Program Co-Chairs: Jerome Barakos, MD & Michael McDermott, MD
FINAL PROGRAM
Friday March 12, 2004
6:00 – 9:00 PM Registration in the Blue Oak Room
7:30 – 9:30 PM President’s Reception – in the Stone Building
Saturday March 13, 2004
7:00 AM Breakfast Buffet, Registration & Exhibits in the Blue Oak Room
& Patio
8:00–9:00 AM Spouse Breakfast in the Blue Oak Room & Patio
8 – 8:45 AM Current and Emerging Therapies for Multiple Sclerosis
Treatment, Bruce Cree, MD, PhD, Department of Neurology, UCSF, Multiple
Sclerosis Center, San Francisco, CA, USA
Dr. Cree’s presentation is supported by an unrestricted educational grant
from Pfizer
KEYNOTE PRESENTATION:
8:45 – 9:45 AM Regulation, Litigation and Frustration: Selected
Aspects of Neurosurgery’s Response to Outside Challenges, Ralph G. Dacey,
Jr., MD, Henry G & Edith R. Schwartz Professor and Chairman of
Neurological Surgery, Washington University School of Medicine, St. Louis,
MO
Dr. Dacey’s presentation is partially supported by UCSF, Department of
Neurosurgery
9:45 – 10: 15 AM Coffee Break - Visit the Exhibits in the Blue Oak Room
SESSION I: PAIN AND NERVES
10:15 – 11:00 AM Effective use of IVIg in Neuropathy, Jonathan S.
Katz, MD, Department of Neurology, Stanford University Medical Center,
Palo Alto, CA
Dr. Katz’s presentation is supported by an unrestricted educational grant
from Baxter
11:00 – 11:30 AM Neurochemical Basis of Pain, Michael Rowbotham, MD,
Department of Neurology, UCSF, San Francisco, CA
Dr. Rowbotham’s presentation is supported by an unrestricted educational
grant from Endo Pharmaceuticals
11:30 - 12:00 PM MR Neurography: Imaging of Peripheral Nerves, Cynthia
Chin, MD & Phil Weinstein, MD, Department of Radiology, UCSF, San
Francisco, CA
12:00 – 12:15 PM FXTAS (Fragile X-associated Tremor Ataxia Syndrome): A
Newly Recognized Heritable Cause of Parkinsonism, Claudia Greco, MD,
University of California, Davis, Sacrament, CA
12:15 - 12:30 PM DISCUSSION
12:30 - 6:00 PM Free for Lunch, Annual Golf Tournament & Activities
6:00 – 7:00 PM Reception in the Lobby Piano Lounge
7:00 – 9:00 PM Society Dinner in the Stone Building, Annual Dinner Meeting
Presentation: From Neurosurgeon to Vineyardist! Dr. Thomas Kenefick,
Calistoga, CA.
Dr. Thomas Kenefick, a San Francisco neurosurgeon and member of the SF
Neurological Society will talk about his career change from well known
neurosurgeon to successful wine grower. His grapes are sought by many
local vineyards and he will soon be releasing his own wines. This
presentation will be fun and informative for anyone who has an interest in
wine and/or the inclination to make a drastic career change.
Sunday March 14, 2004
7:00 AM Continental Breakfast & Registration in the Blue Oak Room
8:00 – 9:00 AM Spouse Breakfast in the Blue Oak Room
8:00 – 8:30 AM Henry Newman Award Lecture: Stereotactic
Radiosurgery for Intramedullary Spinal Tumors, Stephen Ryu, MD, Stanford
University Medical Center, Neurological Surgery Resident
8:30 – 9:00 AM Edwin Boldrey Award Lecture: Unique Astrocyte Ribbon
in Adult Human Brain Contains Neural Stem Cells but Lacks Neuronal Chain
Migration, Nader Sanai, MD, UCSF Neurological Surgery Resident
SESSION II: STROKE, AGING & ADVANCES IN IMAGING
9:00 – 9:30 AM Neurochemical Basis of Stroke Protection, Raymond
Swanson, MD, Department of Neurology, UCSF, San Francisco, CA
9:30 –10:00 AM Update on Management of Stroke, David C Tong, MD, Stanford
Stroke Center, Stanford, CA
10:00 – 10:30 AM Coffee Break - Visit the exhibits in the Blue Oak Room
10:30– 11:00 AM Evolving Modalities in Brain Imaging: Latest Developments
in Perfusion, Diffusion, T2 Relaxometry, and Proton MR Spectroscopy,
Soonmee Cha, MD, UCSF School of Medicine, San Francisco, CA.
11:00 – 11:30 AM Memory and Aging, Bruce L. Miller, MD, Department of
Neurology, UCSF, Memory and Aging Center, San Francisco, CA
11:30 – 12:00 PM Updates in Neuroimaging of Multiple Sclerosis, Daniel
Pelletier, MD - UCSF, MS Center, San Francisco, CA
Dr. Pelletier’s presentation is supported by an unrestricted educational
grant from Biogen
12:00 – 12:15 PM Surgery for Falcotentorial Meningiomas, Michael
McDermott, MD, UCSF, San Francisco, CA
12:15 – 12:30 PM DISCUSSION
12:30 – 12:45 PM General Member’s Business Meeting
12:30 PM Adjourn
Educational Objectives & Continuing Medical Education
EDUCATIONAL OBJECTIVES: Individuals attending this meeting will be
able to:
1. Review the current disease modifying therapies for MS and be familiar
with risks/benefits of FDA approved disease modifying therapies
2. Discuss the rationale and study design for ongoing and upcoming
treatment trials in MS and that several promising clinical trials are
currently, or soon will be, enrolling study subjects
3. Compare and discuss off-label usage of treatments available at UCSF for
treatment of refractory MS disease to FDA approved therapies with
illustrative case presentations
4. Discuss the scope of medical malpractice litigation in the US as it
relates to neurosurgery.
5. Describe organized neurosurgery's response to the malpractice problem
and liability crisis.
6. Describe the properties of IVIg and its suspected mechanisms of action
in the treatment of neuromuscular disease.
7. Describe the indications for the use of IVIg in neuromuscular
disorders.
8. Compare and contrast the risk/benefit profile of IVIg versus other
treatment options for autoimmune neuromuscular disease.
9. Apply optimal strategies for dosing and administration if IVIg, for
both short-and long-term therapy, based on current knowledge.
10. Recognize the neurochemical processes triggered by ischemia that lead
to neuronal death and interventions that can interrupt these processes
11. Describe basic technique and clinical application of advanced
neuroimaging: perfusion, diffusion, and spectroscopic MR imaging
12. Discuss quantitative MR Imaging and its application to
neurodegenerative aspects of MS, HMRS, DTI and brain atrophy
WHO SHOULD ATTEND:
Neurologists, neurosurgeons, neuroradiologists, residents and other
physicians interested in research and clinical advances in the
neurosciences.
Accreditation Statement
This is an activity offered by San Francisco Neurological Society, a
CMA-accredited provider. Physicians attending this course may report up to
8 hours of Category 1 credits toward the California Medical Association’s
Certification in Continuing Medical Education and the American Medical
Association’s Physician’s Recognition Award. Each physician should claim
only those hours of credit actually spent in the educational activity.
Faculty Addendum Conflict of Interest Information
The San Francisco Neurological Society has a conflict of interest
policy that requires course faculty to disclose whether or not they have
financial interests or affiliations with organizations with a direct and
substantial interest in the subject matter of their presentations. The
following information was received from course faculty. It is not assumed
that these financial interests or affiliations will have an adverse impact
on faculty presentations. They simply are noted here to fully inform
course participants.
Speakers: The following speakers have indicated that they have a
financial interest/arrangement or affiliation with one or more
organizations that could be perceived as a real or apparent conflict of
interest in the context of the subject of their presentations.
Name
Affiliation
Bruce Cree MD, PhD Grant support from NIH, National Multiple Sclerosis
Society; Honoraria from Biogen-Idec, Serono-Pfizer, Berlex, Teva
Neurosciences
Jonathan Katz, MD Honoraria from Baxter
Bruce Miller, MD Honoraria from Pfizer and Janssen Pharmaceutica
Daniel Pelletier, MD Honoraria from Biogen-Idec
David C. Tong, MD Consultant for & Honoraria from Bristol-Myers Squibb
Co., Sanofi, Boehringer Ingelheim and Wyeth
Michael Rowbotham, MD Honoraria from Endo Pharmaceuticals
The following speakers have indicated that they have no actual or
potential conflict of interest in relation to this program:
Soonmee Cha, MD, Ralph Dacey, MD, , Cynthia Chin, MD, Stephen Ryu, MD,
Nader Sanai, MD and Raymond Swanson, MD
Discussion of Off-Label or Investigational Uses
The following speakers have indicated that they will be discussing
Off-Label or Investigations Uses of commercial products in their
presentation: Bruce Cree, MD, PhD, And Jonathan Katz, MD
|
|
Home
Membership
Newsletters
Sponsors
Board of
Directors
Related
Links
|
